Just days after the World Health Organization (WHO) joined the COVAX alliance, China extended its coronavirus vaccine use to immediate use in three more cities, to evenly distribute COVID-19 vaccines worldwide is.
Official media reports state that three more cities in eastern China’s Zhejiang province are stepping up efforts to offer the COVID-19 vaccine for immediate use, before they can prioritize groups important to the general public , Official media reports said.
The cities of Yiwu, Ningbo and Shaoxing are targeting key groups in urgent need of vaccination against COVID-19 after the city of Jiaxing, as reported on Saturday, as reported on Saturday by Global Times, another daily The Quoted the paper.
Earlier on Thursday, health officials in Jiaxing announced that the city was administering inactivated COVID-19 vaccines among high-risk groups and would gradually provide it to ordinary citizens for immediate use.
According to the report, emergency vaccination in Yiwu, an internationally renowned manufacturing hub, has officially been discontinued.
On Friday afternoon, about 20 people visited the Community Health Center to receive vaccinations against COVID-19 within an hour.
Most recipients plan to go abroad or plan to go abroad in the near future.
Health officials in Yiwu said COVID-19 shots have arrived in the local medical system and are limited to a small fraction of the population in need of emergency vaccination, including frontline medical staff, personnel who would ensure the city’s basic operations Are, and public officials who report in the Global Times said that official duties require traveling to high-risk countries and regions.
It also states that there are no plans to make the vaccine available to the general public at that time, but when the vaccine is officially available in the market, there may be an abundant supply.
China joined the WHO’s COVAX alliance in an astonishing move on 9 October to evenly distribute speculation ending COVID-19, leading to the pandemic since it emerged in Wuhan in December last year. It plans to supply its vaccines to developing countries to improve its image.
All 11 vaccines in China are in various stages of testing and are awaiting final approval.
COVAX is a global initiative that aims to provide equal access to safe and effective vaccines to countries around the world by working with vaccine manufacturers once they are licensed and approved.
China has roped in more than a dozen countries to conduct end-stage trials of Chinese-made experimental COVID-19 vaccines and has even begun vaccinating thousands of emergency workers.
Yang Sheng, deputy director of the National Medical Products Administration’s Drug Registration Bureau, said earlier that four of China’s developed COVID-19 vaccines have begun the final phase of human trials abroad after receiving approval from foreign authorities.
China is focusing on developing five types of vaccines, and each method has access to at least one clinical trial.
In total, 11 vaccine candidates are in various stages of testing, with Yang being quoted earlier by official media.
Zheng Zhongwei, head of China’s Vaccine Development Task Force, said China’s annual capacity to produce the COVID-19 vaccine was expected to reach 610 million doses this year and one billion doses by 2021.
The WHO stated that nine candidate vaccines are currently being evaluated for inclusion in the COVAX facility.
These include two from China, two from the US, one from the Republic of Korea, one from the UK and Northern Ireland, and a global, multi-producer partnership.
Two of these are in Phase I trials, two are technology transfers and the rest are in the discovery phase.
Coronavirus has so far claimed 4,634 lives in China with 85,672 confirmed infections.
(Except for the headline, this story has not been edited by NDTV staff and published from a syndicated feed.)